Procter & Gamble Hygiene and Health Care Limited Reports ₹43,165 Lakh Profit Before Tax for H1 FY2027 Ending September 30, 2026
Company posts ₹26,202 lakh profit before tax in Q2 with revenue from operations at ₹1,14,558 lakh, as per unaudited financial results
Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027. Total revenue from operations reached ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1, with detailed cost and cash flow statements included.
Procter & Gamble Hygiene and Health Care Limited
Financial Results
Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027.
The company reported revenue from operations of ₹1,14,558 lakh for the quarter and ₹2,03,654 lakh for the half year ended September 30, 2026.
Total income including other income was ₹1,16,209 lakh for Q2 and ₹2,06,298 lakh for H1.
Expenses for Q2 stood at ₹90,007 lakh and ₹1,63,133 lakh for H1, covering raw material costs, stock purchases, and employee benefits among others.
The profit after tax was ₹19,584 lakh for the quarter and ₹32,211 lakh for the half year.
Earnings per share for the quarter were ₹60.33 basic and diluted, and ₹99.23 basic with ₹123.82 diluted for the half year, based on a ₹10 face value per share.
Highlights
- Profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027.
- Revenue from operations of ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1.
- Profit after tax recorded at ₹19,584 lakh for Q2 and ₹32,211 lakh for H1.
- Earnings per share of ₹60.33 basic and ₹60.33 diluted for Q2.
- Unaudited financial results subject to limited review by statutory auditors.
- Segment reporting combines health care and hygiene products under single primary segment per Ind AS 108.
Key Data Snapshot
What happened
- Procter & Gamble Hygiene and Health Care Limited approved unaudited financial results for quarter and half year ended September 30, 2026.
- Reported total revenue from operations of ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1 FY2027.
- Recorded a profit before tax of ₹26,202 lakh in Q2 and ₹43,165 lakh in H1 FY2027.
- Profit after tax amounts to ₹19,584 lakh for Q2 and ₹32,211 lakh for the half year.
Key details
- Earnings per share for Q2 were ₹60.33 basic and ₹60.33 diluted for a face value of ₹10 per equity share.
- For the half year, basic earnings per share stood at ₹99.23 and diluted at ₹123.82.
- Expenses include cost of raw materials, stock purchases, employee benefits, finance costs, depreciation, advertising, and other expenses.
- Financial results have been reviewed by Audit Committee and approved by Board of Directors on November 12, 2026.
- The results have undergone limited review by statutory auditors as per SEBI regulations.
Financial performance
- Total income including other income was ₹1,16,209 lakh in Q2 and ₹2,06,298 lakh in H1 FY2027.
- Total expenses were ₹90,007 lakh for Q2 and ₹1,63,133 lakh for H1 FY2027.
- Income tax expenses (current and deferred) totaled ₹6,618 lakh in Q2 and ₹10,954 lakh in H1 FY2027.
- Profit after tax and other comprehensive income totaled ₹19,571 lakh for Q2 and ₹32,305 lakh for H1 FY2027.
Regulatory and governance context
- Unaudited financial statements prepared as per Indian Accounting Standard 34 (Ind AS 34)
- Reports prepared in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Segment reporting consolidates health care and hygiene product lines into a single reportable segment.
- Board meeting for approval held on November 12, 2026.
Highlights
- Profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027.
- Revenue from operations of ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1.
- Profit after tax recorded at ₹19,584 lakh for Q2 and ₹32,211 lakh for H1.
- Earnings per share of ₹60.33 basic and ₹60.33 diluted for Q2.
- Unaudited financial results subject to limited review by statutory auditors.
- Segment reporting combines health care and hygiene products under single primary segment per Ind AS 108.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 'Interim Financial Reporting' (Ind AS 34)
- Companies Act, 2013 Section 133
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Kaynes Technology India Limited Reports Q2 FY2027 Un-audited Results and Enters Joint Venture to Produce TFT Modules
Kaynes Technology India Limited released its un-audited financial results for the quarter and half year ended September 30, 2026, and approved a joint venture with Toyokawa Techno Private Limited to produce Thin-Film Transistor Display Modules in India, while proposing voluntary strike-off of a subsidiary.
Read Full StoryITI Limited Reports ₹49,528 Lakh Revenue and ₹6,368 Lakh Consolidated Loss Before Tax for Half Year Ending September 2026
ITI Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026, revealing total consolidated revenue of ₹49,528 lakh for the quarter and a consolidated loss before tax of ₹6,368 lakh for the half-year period.
Read Full StoryZetwerk Manufacturing Businesses Limited Reports Q2 FY2027 Loss with Rs. 886.06 Million Receivables Dispute, Appoints New Company Secretary
Zetwerk Manufacturing Businesses Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, reporting a loss before tax of Rs. 1,193.17 million for the quarter. The company highlighted ongoing litigation over receivables totaling Rs. 886.06 million, alongside key administrative updates.
Read Full Story